Evidence map›Paper›PMID 39072698›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2024

Renal IL-23-Dependent Type 3 Innate Lymphoid Cells Link Crystal-induced Intrarenal Inflammasome Activation with Kidney Fibrosis.

Teresa M Frasconi, Christian Kurts, Ermanila Dhana, Romina Kaiser, Miriam Reichelt, Veronika Lukacs-Kornek, Peter Boor, Anja E Hauser, Anna Pascual-Reguant, Sammy Bedoui and 3 more

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Teresa M FrasconiInstitute of Molecular Medicine and Experimental Immunology, University Hospital Bonn, Bonn, Germany.
Christian KurtsInstitute of Molecular Medicine and Experimental Immunology, University Hospital Bonn, Bonn, Germany.ORCID 0000-0002-6620-2401
Ermanila DhanaInstitute of Molecular Medicine and Experimental Immunology, University Hospital Bonn, Bonn, Germany.ORCID 0009-0007-1639-7953
Romina KaiserInstitute of Molecular Medicine and Experimental Immunology, University Hospital Bonn, Bonn, Germany.ORCID 0009-0000-4906-5540
Miriam ReicheltInstitute of Molecular Medicine and Experimental Immunology, University Hospital Bonn, Bonn, Germany.
Veronika Lukacs-KornekInstitute of Molecular Medicine and Experimental Immunology, University Hospital Bonn, Bonn, Germany.
Peter BoorInstitute of Pathology, Department of Nephrology, RWTH University, Aachen, Germany.ORCID 0000-0001-9921-4284
Anja E HauserDepartment of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.ORCID 0000-0002-7725-9526
Anna Pascual-ReguantDepartment of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.ORCID 0000-0002-5042-3699
Sammy BedouiDepartment of Microbiology and Immunology, Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia.
Jan-Eric TurnerIII Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Janine Becker-GototInstitute of Molecular Medicine and Experimental Immunology, University Hospital Bonn, Bonn, Germany.ORCID 0000-0003-1190-2133
Isis Ludwig-PortugallInstitute of Molecular Medicine and Experimental Immunology, University Hospital Bonn, Bonn, Germany.ORCID 0000-0002-9463-7111

Funding

Deutsche Forschungsgemeinschaft (DFG) 264599542Deutsche Forschungsgemeinschaft (DFG) 272482170Deutsche Forschungsgemeinschaft (DFG) 273942223Deutsche Forschungsgemeinschaft (DFG) 322900939Deutsche Forschungsgemeinschaft (DFG) 36842431Deutsche Forschungsgemeinschaft (DFG) 386793560Deutsche Forschungsgemeinschaft (DFG) 390873048Deutsche Forschungsgemeinschaft (DFG) 432325352Deutsche Forschungsgemeinschaft (DFG) 432698239Deutsche Forschungsgemeinschaft (DFG) 445703531Deutsche Forschungsgemeinschaft (DFG) 454024652Deutsche Forschungsgemeinschaft (DFG) 466687329
6 · The paper itself

Abstract

Chronic inflammasome activation in mononuclear phagocytes (MNPs) promotes fibrosis in various tissues, including the kidney. The cellular and molecular links between the inflammasome and fibrosis are unclear. To address this question, we fed mice lacking various immunological mediators an adenine-enriched diet, which causes crystal precipitation in renal tubules, crystal-induced inflammasome activation, and renal fibrosis. We found that kidney fibrosis depended on an intrarenal inflammasome-dependent type 3 immune response driven by its signature transcription factor Rorc (retinoic acid receptor-related orphan receptor C gene), which was partially carried out by type 3 innate lymphoid cells (ILC3s). The role of ILCs in the kidney is less well known than in other organs, especially that of ILC3. In this article, we describe that depletion of ILCs or genetic deficiency for Rorc attenuated kidney inflammation and fibrosis. Among the inflammasome-derived cytokines, only IL-1β expanded ILC3 and promoted fibrosis, whereas IL-18 caused differentiation of NKp46+ ILC3. Deficiency of the type 3 maintenance cytokine, IL-23, was more protective than IL-1β inhibition, which may be explained by the downregulation of the IL-1R, but not of the IL-23R, by ILC3 early in the disease, allowing persistent sensing of IL-23. Mechanistically, ILC3s colocalized with renal MNPs in vivo as shown by multiepitope-ligand cartography. Cell culture experiments indicated that renal ILC3s caused renal MNPs to increase TGF-β production that stimulated fibroblasts to produce collagen. We conclude that ILC3s link inflammasome activation with kidney inflammation and fibrosis and are regulated by IL-1β and IL-23.

Indexed as

FibrosisImmunity, InnateInflammasomesInterleukin-23LymphocytesNuclear Receptor Subfamily 1, Group F, Member 3AnimalsInterleukin-1betaKidneyKidney DiseasesMiceMice, Inbred C57BLMice, KnockoutInflammasomesInterleukin-1betaInterleukin-23Nuclear Receptor Subfamily 1, Group F, Member 3Rorc protein, mouse

Identifiers

PMID39072698
PMCPMC11372247

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.